Your browser doesn't support javascript.
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.
Fan, Yong; Geng, Yan; Wang, Yu; Deng, Xuerong; Li, Guangtao; Zhao, Juan; Ji, Lanlan; Zhang, Xiaohui; Song, Zhibo; Zhang, Haoze; Sun, Xiaoying; Gao, Dai; Xie, Wenhui; Huang, Hong; Hao, YanJie; Zhang, Zhuoli.
  • Fan Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Geng Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Wang Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Deng X; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Li G; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Zhao J; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Ji L; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Zhang X; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Song Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Zhang H; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Sun X; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Gao D; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Xie W; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Huang H; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Hao Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China zhuoli.zhang@126.com.
Ann Rheum Dis ; 81(3): 443-445, 2022 03.
Article in English | MEDLINE | ID: covidwho-1537896
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2021-221736

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2021-221736